These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2894780)

  • 1. Differential memory function with dopaminergic versus anticholinergic treatment of drug-induced extrapyramidal symptoms.
    Fayen M; Goldman MB; Moulthrop MA; Luchins DJ
    Am J Psychiatry; 1988 Apr; 145(4):483-6. PubMed ID: 2894780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amantadine versus trihexyphenidyl in the treatment of neuroleptic-induced parkinsonism.
    Fann WE; Lake CR
    Am J Psychiatry; 1976 Aug; 133(8):940-3. PubMed ID: 782262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function.
    McEvoy JP
    J Clin Psychiatry; 1987 Sep; 48 Suppl():20-3. PubMed ID: 2887553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophrenia.
    McEvoy JP; McCue M; Freter S
    Clin Ther; 1987; 9(4):429-33. PubMed ID: 2886223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A double-blind study on the effect of dexetimide in the control of neuroleptic-induced extrapyramidal side-effects].
    Chen Y
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Aug; 24(4):197-9, 251. PubMed ID: 1683277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The need for continuous use of antiparkinsonian medication with chronic schizophrenic patients receiving long-term neuroleptic therapy.
    Manos N; Gkiouzepas J; Logothetis J
    Am J Psychiatry; 1981 Feb; 138(2):184-8. PubMed ID: 6109453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers.
    McEvoy JP; McCue M; Spring B; Mohs RC; Lavori PW; Farr RM
    Am J Psychiatry; 1987 May; 144(5):573-7. PubMed ID: 3578566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of anticholinergic agents on patients with tardive dyskinesia and concomitant drug-induced parkinsonism.
    Wirshing WC; Freidenberg DL; Cummings JL; Bartzokis G
    J Clin Psychopharmacol; 1989 Dec; 9(6):407-11. PubMed ID: 2574192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in verbal learning of patients with schizophrenia: Results from a randomized, double-blind, placebo-controlled trial of amantadine adjunctive to antipsychotics.
    Czepielewski LS; Sodré L; Souza AC; Bücker J; Burke KP; Ceresér KM; Gama CS
    Schizophr Res; 2015 Oct; 168(1-2):571-2. PubMed ID: 26104472
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum neuroleptic and anticholinergic activity in relationship to cognitive toxicity of antiparkinsonian agents in schizophrenic patients.
    Hitri A; Craft RB; Fallon J; Sethi R; Sinha D
    Psychopharmacol Bull; 1987; 23(1):33-7. PubMed ID: 2885890
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug levels and antiparkinsonian drugs in neuroleptic-treated schizophrenic patients.
    Hitri A; Craft RB; Sethi R; Sinha D
    Clin Neuropharmacol; 1987 Jun; 10(3):261-71. PubMed ID: 2900683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the need for prophylactic antiparkinsonian medication in psychotic patients treated with neuroleptics.
    Manos N; Lavrentiadis G; Gkiouzepas J
    J Clin Psychiatry; 1986 Mar; 47(3):114-6. PubMed ID: 2869027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of amantadine in drug-induced extrapyramidal disorders.
    DiMascio A; Bernardo DL; Greenblatt DJ; Marder JE
    Arch Gen Psychiatry; 1976 May; 33(5):599-602. PubMed ID: 5066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical management of acute neuroleptic-induced extrapyramidal syndromes.
    Keepers GA; Casey DE
    Curr Psychiatr Ther; 1986; 23():139-57. PubMed ID: 2870879
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind comparison of the efficacy of EX 10-029 and trihexyphenidyl hydrochloride in relieving drug-induced Parkinsonian symptoms.
    Freeman H; Mehta IS
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):470-7. PubMed ID: 4629309
    [No Abstract]   [Full Text] [Related]  

  • 17. A placebo-controlled trial of trihexyphenidyl in unmedicated patients with schizophrenia.
    Goff DC; Amico E; Dreyfuss D; Ciraulo D
    Am J Psychiatry; 1994 Mar; 151(3):429-31. PubMed ID: 8109654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticholinergic effects on memory: benztropine versus amantadine.
    Gelenberg AJ; Van Putten T; Lavori PW; Wojcik JD; Falk WE; Marder S; Galvin-Nadeau M; Spring B; Mohs RC; Brotman AW
    J Clin Psychopharmacol; 1989 Jun; 9(3):180-5. PubMed ID: 2661606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of trihexphenidyl (Artane) on memory in schizophrenic patients.
    Fennig S; Levine Y; Naisberg S; Elizur A
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(1):71-8. PubMed ID: 3299495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amantadine in the management of extrapyramidal side effects.
    Borison RL
    Clin Neuropharmacol; 1983; 6 Suppl 1():S57-63. PubMed ID: 6139167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.